Vivos Therapeutics (VVOS) Asset Utilization Ratio (2021 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Asset Utilization Ratio of 0.78 for Q1 2026, down 29.2% year-over-year from 1.1 in Q1 2025, and up 13.53% quarter-over-quarter from 0.69 in Q4 2025.
Vivos Therapeutics (VVOS) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Asset Utilization Ratio for 6 consecutive years, with 0.78 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 29.2% year-over-year to 0.78; the TTM figure through Mar 2026 stood at 0.78 (down 29.2% YoY), while the FY2025 annual figure was 0.86, down 25.34% from the prior year.
- Asset Utilization Ratio rose to 0.78 in Q1 2026 per VVOS's latest filing, from 0.69 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.31 in Q4 2023 and bottomed at 0.54 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 0.92 across 5 years, with a median of 0.98 in 2024.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 120.75% — and 2025, when it slumped 30.02%.
- Vivos Therapeutics' Asset Utilization Ratio stood at 1.0 in 2022, then jumped by 31.44% to 1.31 in 2023, then slipped by 25.16% to 0.98 in 2024, then plunged by 30.02% to 0.69 in 2025, then increased by 13.53% to 0.78 in 2026.
- Business Quant data shows VVOS's Asset Utilization Ratio at 0.78 in Q1 2026, 0.69 in Q4 2025, and 0.67 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 0.42 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 0.55 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 0.47 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 0.48 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 0.76 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 0.57 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 0.80 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 0.56 |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | 0.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.78 |
| Dec 31, 2025 | 0.69 |
| Sep 30, 2025 | 0.67 |
| Jun 30, 2025 | 0.77 |
| Mar 31, 2025 | 1.10 |
| Dec 31, 2024 | 0.98 |
| Sep 30, 2024 | 0.94 |
| Jun 30, 2024 | 1.01 |
| Mar 31, 2024 | 1.19 |
| Dec 31, 2023 | 1.31 |
| Sep 30, 2023 | 1.21 |
| Jun 30, 2023 | 1.00 |
| Mar 31, 2023 | 1.05 |
| Dec 31, 2022 | 1.00 |
| Sep 30, 2022 | 0.77 |
| Jun 30, 2022 | 0.62 |
| Mar 31, 2022 | 0.54 |
| Dec 31, 2021 | 0.45 |
| Sep 30, 2021 | 0.36 |
| Jun 30, 2021 | 0.43 |